Schubert & CO Edwards Lifesciences Corp Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$74.26 - $84.51 $445 - $507	6 Added 46.15%	19 $1,000
Q4 2022 Jan 31, 2023	BUY	$68.3 - $87.44 $136 - $174	2 Added 18.18%	13 $0
Q3 2022 Oct 21, 2022	SELL	$82.37 - $107.29 $164 - $214	-2 Reduced 15.38%	11 $1,000
Q2 2022 Aug 01, 2022	SELL	$86.5 - $128.27 $86 - $128	-1 Reduced 7.14%	13 $1,000
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $305 - $385	3 Added 27.27%	14 $2,000
Q4 2021 Jan 28, 2022	BUY	$106.37 - $130.68 $1,170 - $1,437	11 New	11 $1,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.